Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | RAD52 | P43351 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4188473 | 1.00 | HRH3 (0.52) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL917669 | 0.98 | HRH3 (0.48) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL929713 | 0.94 | HRH3 (0.56) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL4015873 | 0.92 | HRH3 (0.60) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL4015864 | 0.92 | HRH3 (0.60) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL11803303 | 0.92 | HRH3 (0.60) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL4016061 | 0.92 | HRH3 (0.60) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL4021101 | 0.92 | HRH3 (0.60) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL4022292 | 0.92 | HRH3 (0.60) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 | |
| SCHEMBL4017075 | 0.92 | HRH3 (0.60) | HRH3SMN1; SMN2MAPK1CYP1A2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230279290-A1 | COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS | MESO SCALE TECHNOLOGIES LLC (US) | 2023-09-07 | — | — | US | claimed |
| WO-2023129884-A1 | METHODS FOR ELECTROCHEMILUMINESCENCE DETECTION | MESO SCALE TECHNOLOGIES, LLC. (US) | 2023-07-06 | — | — | WO | claimed |
| US-20210109100-A1 | KITS SUITABLE FOR USE IN ELECTROCHEMILUMINESCENCE METHODS AND METHODS OF EFFECTING A SPECIFIC-BINDING NON-WASH ASSAY | MESO SCALE TECHNOLOGIES, LLC. (US) | 2021-04-15 | — | — | US | claimed |
| US-10753934-B2 | Kits suitable for use in electrochemiluminescence methods and methods of effecting a specific-binding non-wash assay | MESO SCALE TECHNOLOGIES, LLC. (US) | 2020-08-25 | — | — | US | claimed |
| EP-1436598-B1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES LLC (US) | 2013-11-27 | — | — | EP | claimed |
| US-8477477-B2 | Power storage device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-07-02 | — | — | US | claimed |
| US-20110075325-A1 | POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-31 | — | — | US | claimed |
| EP-1893990-A2 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-03-05 | — | — | EP | claimed |
| EP-1436598-A4 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES LLC (US) | 2007-10-31 | — | — | EP | claimed |
| WO-2007053191-A9 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | UNIV TEXAS (US) | 2007-08-09 | — | — | WO | claimed |
| WO-2007053191-A2 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | UNIVERSITY OF TEXAS SYSTEM (US) | 2007-05-10 | — | — | WO | claimed |
| US-6919173-B2 | Electrochemiluminescence; kinases; phosphatases | MESO SCALE TECHNOLOGIES, LLC. (US) | 2005-07-19 | — | — | US | claimed |
| US-20050090523-A1 | 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, or Alzheimer's disease; 2-[4-[3-(Piperidino)propylamino]phenyl]-8-methylimidazo[1,2-a]pyridine for example | BREITENBUCHER J G (US) | 2005-04-28 | — | — | US | claimed |
| EP-1436598-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | Meso Scale Technologies LLC (US) | 2004-07-14 | — | — | EP | claimed |
| EP-1417169-A2 | SELECTIVE ESTROGEN RECEPTOR MODULATORS | Bristol-Myers Squibb Pharma Company (US) | 2004-05-12 | — | — | EP | claimed |
| US-20030175803-A1 | Electrochemiluminescence; kinases; phosphatases | MESO SCALE TECHNOLOGIES, LLC. | 2003-09-18 | — | — | US | claimed |
| US-20030105148-A1 | Selective estrogen receptor modulators | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-06-05 | — | — | US | claimed |
| WO-2003023380-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES, LLC (US) | 2003-03-20 | — | — | WO | claimed |
| WO-2003016270-A2 | SELECTIVE ESTROGEN RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2003-02-27 | — | — | WO | claimed |
| US-20230279290-A1 | COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS | MESO SCALE TECHNOLOGIES LLC (US) | 2023-09-07 | — | — | US | disclosed |
| WO-2023129884-A1 | METHODS FOR ELECTROCHEMILUMINESCENCE DETECTION | MESO SCALE TECHNOLOGIES, LLC. (US) | 2023-07-06 | — | — | WO | disclosed |
| CN-116284848-A | Method for dissolving chitosan/cellulose by using multifunctional acidic ionic liquid | 南京工业大学 | 2023-06-23 | — | — | CN | disclosed |
| US-20210246344-A1 | Biological buffers with wide buffering ranges | DALY THOMAS (US) | 2021-08-12 | — | — | US | disclosed |
| US-20210109100-A1 | KITS SUITABLE FOR USE IN ELECTROCHEMILUMINESCENCE METHODS AND METHODS OF EFFECTING A SPECIFIC-BINDING NON-WASH ASSAY | MESO SCALE TECHNOLOGIES, LLC. (US) | 2021-04-15 | — | — | US | disclosed |
| US-10753934-B2 | Kits suitable for use in electrochemiluminescence methods and methods of effecting a specific-binding non-wash assay | MESO SCALE TECHNOLOGIES, LLC. (US) | 2020-08-25 | — | — | US | disclosed |
| US-20200071582-A1 | Biological Buffers with Wide Buffering Ranges | TPAT IP LLC | 2020-03-05 | — | — | US | disclosed |
| US-20180238882-A1 | KITS SUITABLE FOR USE IN ELECTROCHEMILUMINESCENCE METHODS AND METHODS OF EFFECTING A SPECIFIC-BINDING NON-WASH ASSAY | MESO SCALE TECHNOLOGIES, LLC. (US) | 2018-08-23 | — | — | US | disclosed |
| EP-1893990-B1 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | UNIV TEXAS (US) | 2018-05-02 | — | — | EP | disclosed |
| US-9891221-B2 | Kits suitable for use in electrochemiluminescence methods and methods of effecting a specific-binding non-wash assay | MESO SCALE TECHNOLOGIES, LLC. (US) | 2018-02-13 | — | — | US | disclosed |
| CN-101597196-B | Improved drug candidate and preparation method thereof | JIYAKETA CO., LTD. (CH) | 2016-05-04 | — | — | CN | disclosed |
| US-20140336070-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES LLC (US) | 2014-11-13 | — | — | US | disclosed |
| US-8840774-B2 | Electrochemistry and electrogenerated chemiluminescence with a single faradaic electrode | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-09-23 | — | — | US | disclosed |
| US-8785201-B2 | Assay buffer, compositions containing the same, and methods of using the same | MESO SCALE TECHNOLOGIES, LLC (US) | 2014-07-22 | — | — | US | disclosed |
| EP-1646659-B1 | METHOD FOR THE PREPARATION OF 1,3-PROPANE DISULFONIC ACID COMPOUNDS | KIACTA S RL (CH) | 2014-05-14 | — | — | EP | disclosed |
| US-20140116887-A1 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-05-01 | — | — | US | disclosed |
| US-8702958-B2 | Electrochemistry and electrogenerated chemiluminescence with a single faradaic electrode | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-04-22 | — | — | US | disclosed |
| EP-1436598-B1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES LLC (US) | 2013-11-27 | — | — | EP | disclosed |
| US-8477477-B2 | Power storage device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-8477477-B2 | Power storage device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-8477477-B2 | Power storage device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-8477477-B2 | Power storage device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-07-02 | — | — | US | disclosed |
| US-20120312700-A1 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2012-12-13 | — | — | US | disclosed |
| US-8211279-B2 | Electrochemistry and electrogenerated chemiluminescence with a single faradaic electrode | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110075325-A1 | POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110075325-A1 | POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110075325-A1 | POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110075325-A1 | POWER STORAGE DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-03-31 | — | — | US | disclosed |
| US-20110021813-A1 | PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | KONG XIANQI | 2011-01-27 | — | — | US | disclosed |
| US-20100190753-A1 | Methods and Compositions for Treating Amyloid-Related Diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2010-07-29 | — | — | US | disclosed |
| US-20100190753-A1 | Methods and Compositions for Treating Amyloid-Related Diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2010-07-29 | — | — | US | disclosed |
| CN-101597196-A | Improved drug candidate and preparation method thereof | BELLUS HEALTH INTERNAT LTD (CH) | 2009-12-09 | — | — | CN | disclosed |
| US-7598269-B2 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2009-10-06 | — | — | US | disclosed |
| US-7598269-B2 | Methods and compositions for treating amyloid-related diseases | BELLUS HEALTH (INTERNATIONAL) LIMITED (CH) | 2009-10-06 | — | — | US | disclosed |
| CN-100528840-C | Improved drug candidates and methods for their preparation | NEUROCHEM INTERNAT LTD (CH) | 2009-08-19 | — | — | CN | disclosed |
| US-20090170121-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES, LLC. (US) | 2009-07-02 | — | — | US | disclosed |
| EP-1085540-B1 | SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PREPARING THE SAME | SHOWA DENKO KK (JP) | 2009-07-01 | — | — | EP | disclosed |
| US-7491540-B2 | Comprisese water, piperazine-N,N'-bis(2-ethanesulfonic acid), electrolyte comprising buffer selected from tris(hydroxymethyl)aminomethane, glycylglycine and phosphate, phenyl ether-containing surfactant, and optionally preservative; electroluminescence | MESO SCALE TECHNOLOGIES, LLC (US) | 2009-02-17 | — | — | US | disclosed |
| WO-2008045819-A2 | DETECTION AND IDENTIFICATION OF ORGANISMS VIA ANALYSIS OF NUCLEIC ACID SEQUENCES | BIOVERIS CORPORATION (US) | 2008-04-17 | — | — | WO | disclosed |
| EP-1893990-A2 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-03-05 | — | — | EP | disclosed |
| US-20080027097-A1 | PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2008-01-31 | — | — | US | disclosed |
| US-7323587-B2 | Selective estrogen receptor modulators | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2008-01-29 | — | — | US | disclosed |
| US-20080015180-A1 | Methods and compositions for treating amyloid-related diseases | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2008-01-17 | — | — | US | disclosed |
| US-20080015180-A1 | Methods and compositions for treating amyloid-related diseases | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2008-01-17 | — | — | US | disclosed |
| EP-1436598-A4 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES LLC (US) | 2007-10-31 | — | — | EP | disclosed |
| US-7288410-B2 | Electrochemiluminescence assays; aqueous reagent composition consisting of water, tripropylamine 50 mM-1000 mM and an electrolyte comprising a pH buffer selected from tris(hydroxymethyl)aminomethane and glycylglycine, pH of 6.5-8.5; improved sensitivity | MESO SCALE TECHNOLOGIES, LLC. (US) | 2007-10-30 | — | — | US | disclosed |
| WO-2007053191-A9 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | UNIV TEXAS (US) | 2007-08-09 | — | — | WO | disclosed |
| US-7253306-B2 | Pharmaceutical drug candidates and methods for preparation thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-08-07 | — | — | US | disclosed |
| US-7244764-B2 | Methods and compositions for treating amyloid-related diseases | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-07-17 | — | — | US | disclosed |
| US-7244764-B2 | Methods and compositions for treating amyloid-related diseases | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-07-17 | — | — | US | disclosed |
| US-20070116600-A1 | Detection device and methods associated therewith | BIOVERIS CORPORATION | 2007-05-24 | — | — | US | disclosed |
| WO-2007053191-A2 | ELECTROCHEMISTRY AND ELECTROGENERATED CHEMILUMINESCENCE WITH A SINGLE FARADAIC ELECTRODE | UNIVERSITY OF TEXAS SYSTEM (US) | 2007-05-10 | — | — | WO | disclosed |
| US-7199117-B2 | Phenyl-substituted imidazopyridines | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2007-04-03 | — | — | US | disclosed |
| US-20070034529-A1 | Electrochemistry and electrogenerated chemiluminescence with a single faradaic electrode | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2007-02-15 | — | — | US | disclosed |
| WO-2007002580-A2 | DIAGNOSTIC AS SAY SYSTEM WITH MULTI -WELL REAGENT CONTAINER | BIOVERIS CORPORATION (US) | 2007-01-04 | — | — | WO | disclosed |
| CN-1839117-A | Improved drug candidates and methods for their preparation | NEUROCHEM INTERNAT LTD (CH) | 2006-09-27 | — | — | CN | disclosed |
| US-7087757-B2 | Phenyl-substituted imidazopyridines | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2006-08-08 | — | — | US | disclosed |
| US-7045540-B2 | Selective estrogen receptor modulators | BRISTOL MEYERS SQUIBB COMPANY (US) | 2006-05-16 | — | — | US | disclosed |
| US-7041827-B2 | Phenyl-substituted imidazopyridines | BREITENBUCHER J GUY | 2006-05-09 | — | — | US | disclosed |
| US-7041828-B2 | Phenyl-substituted imidazopyridines | BREITENBUCHER J GUY | 2006-05-09 | — | — | US | disclosed |
| EP-1646659-A2 | IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | Neurochem (International) Limited (CH) | 2006-04-19 | — | — | EP | disclosed |
| US-20050267183-A1 | Selective estrogen receptor modulators | KALTENBACH ROBERT F | 2005-12-01 | — | — | US | disclosed |
| US-20050245602-A1 | Selective estrogen receptor modulators | KALTENBACH ROBERT F | 2005-11-03 | — | — | US | disclosed |
| EP-1051655-B1 | METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY | ISTA PHARMACEUTICALS INC (US) | 2005-09-28 | — | — | EP | disclosed |
| US-6927224-B2 | Selective estrogen receptor modulators | BRISTOL MYERS SQUIBB COMPANY (US) | 2005-08-09 | — | — | US | disclosed |
| US-6919173-B2 | Electrochemiluminescence; kinases; phosphatases | MESO SCALE TECHNOLOGIES, LLC. (US) | 2005-07-19 | — | — | US | disclosed |
| US-20050143462-A1 | Pharmaceutical drug candidates and methods for preparation thereof | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-06-30 | — | — | US | disclosed |
| US-20050136048-A1 | Electrochemiluminescence assays; aqueous reagent composition consisting of water, tripropylamine 50 mM-1000 mM and an electrolyte comprising a pH buffer selected from tris(hydroxymethyl)aminomethane and glycylglycine, pH of 6.5-8.5; improved sensitivity | MESO SCALE TECHNOLOGIES, LLC. | 2005-06-23 | — | — | US | disclosed |
| US-20050136497-A1 | Comprisese water, piperazine-N,N'-bis(2-ethanesulfonic acid), electrolyte comprising buffer selected from tris(hydroxymethyl)aminomethane, glycylglycine and phosphate, phenyl ether-containing surfactant, and optionally preservative; electroluminescence | MESO SCALE TECHNOLOGIES, LLC. | 2005-06-23 | — | — | US | disclosed |
| US-6908929-B2 | Phenyl-substituted imidazopyridines | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2005-06-21 | — | — | US | disclosed |
| US-20050090523-A1 | 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, or Alzheimer's disease; 2-[4-[3-(Piperidino)propylamino]phenyl]-8-methylimidazo[1,2-a]pyridine for example | BREITENBUCHER J G (US) | 2005-04-28 | — | — | US | disclosed |
| US-20050085502-A1 | Phenyl-substituted imidazopyridines | BREITENBUCHER J G (US) | 2005-04-21 | — | — | US | disclosed |
| US-20050085501-A1 | Phenyl-substituted imidazopyridines | BREITENBUCHER J G (US) | 2005-04-21 | — | — | US | disclosed |
| US-20050049277-A1 | Phenyl-substituted imidazopyridines | BREITENBUCHER J GUY (US) | 2005-03-03 | — | — | US | disclosed |
| US-20050043348-A1 | Phenyl-substituted imidazopyridines | BREITENBUCHER J GUY (US) | 2005-02-24 | — | — | US | disclosed |
| WO-2004113391-A2 | IMPROVED PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2004-12-29 | — | — | WO | disclosed |
| EP-1436598-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | Meso Scale Technologies LLC (US) | 2004-07-14 | — | — | EP | disclosed |
| EP-1417169-A2 | SELECTIVE ESTROGEN RECEPTOR MODULATORS | Bristol-Myers Squibb Pharma Company (US) | 2004-05-12 | — | — | EP | disclosed |
| US-20030175803-A1 | Electrochemiluminescence; kinases; phosphatases | MESO SCALE TECHNOLOGIES, LLC. | 2003-09-18 | — | — | US | disclosed |
| US-20030105148-A1 | Selective estrogen receptor modulators | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-06-05 | — | — | US | disclosed |
| WO-2003023380-A1 | ASSAY BUFFER, COMPOSITIONS CONTAINING THE SAME, AND METHODS OF USING THE SAME | MESO SCALE TECHNOLOGIES, LLC (US) | 2003-03-20 | — | — | WO | disclosed |
| EP-1051655-A4 | METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY | ISTA PHARMACEUTICALS INC (US) | 2003-03-19 | — | — | EP | disclosed |
| WO-2003016270-A2 | SELECTIVE ESTROGEN RECEPTOR MODULATORS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2003-02-27 | — | — | WO | disclosed |
| EP-1268478-A2 | PHENYL-SUBSTITUTED IMIDAZOPYRIDINES | Ortho McNeil Pharmaceutical, Inc. (US) | 2003-01-02 | — | — | EP | disclosed |
| US-6466421-B1 | Solid electrolytic capacitor and method for producing the same | SHOWA DENKO K.K. (JP) | 2002-10-15 | — | — | US | disclosed |
| US-6344966-B1 | ELECTRICALLY CONDUCTING POLYMER LAYER CONTAINS AS A DOPANT AN ANION OF(1) ALKOXY-SUBSTITUTED NAPHTHALENESULFONATE, (2) A HETEROCYCLIC SULFONATE, OR (3) AN ANION OF AN ALIPHATIC POLYCYCLIC COMPOUND | SHOWA DENKO K.K. (JP) | 2002-02-05 | — | — | US | disclosed |
| US-20020006934-A1 | Phenyl-substituted imidazopyridines | ORTHO MCNEIL PHARMACEUTICAL, INC. | 2002-01-17 | — | — | US | disclosed |
| WO-2001074815-A2 | PHENYL-SUBSTITUTED IMIDAZOPYRIDINES | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| US-20010016731-A1 | Methods and apparatus for accelerated orthokeratology | DEVORE DALE (US) | 2001-08-23 | — | — | US | disclosed |
| EP-1085540-A1 | SOLID ELECTROLYTIC CAPACITOR AND METHOD FOR PREPARING THE SAME | Showa Denko K K (JP) | 2001-03-21 | — | — | EP | disclosed |
| US-6161544-A | Methods for accelerated orthokeratology | KERATOFORM, INC. (US) | 2000-12-19 | — | — | US | disclosed |
| EP-1051655-A1 | METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY | Ista Pharmaceuticals, Inc. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-1999039238-A1 | METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY | KERATOFORM, INC. (US) | 1999-08-05 | — | — | WO | disclosed |
| WO-1999039238-A1 | METHODS AND APPARATUS FOR ACCELERATED ORTHOKERATOLOGY | KERATOFORM, INC. (US) | 1999-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (18 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136048-A1 | Electrochemiluminescence assays; aqueous reagent composition consisting of water, tripropylamine 50 mM-1000 mM and an electrolyte comprising a pH buffer selected from tris(hydroxymethyl)aminomethane and glycylglycine, pH of 6.5-8.5; improved sensitivity | GNMT, TET1, MPG | HRH3 246/4885SMN1; SMN2 3874/4885MAPK1 2999/4885 |
| US-20110021813-A1 | PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | MPST, TTR, STS | HRH3 3688/4885SMN1; SMN2 304/4885MAPK1 1723/4885 |
| US-20050245602-A1 | Selective estrogen receptor modulators | ESR1, ESR2, GPER1 | HRH3 1097/4885SMN1; SMN2 1146/4885MAPK1 2077/4885 |
| US-20050043348-A1 | Phenyl-substituted imidazopyridines | AADAC, DPP4, DPP3 | HRH3 701/4885SMN1; SMN2 2726/4885MAPK1 4541/4885 |
| US-20030105148-A1 | Selective estrogen receptor modulators | ESR1, GPER1, PTGIR | HRH3 503/4885SMN1; SMN2 4731/4885MAPK1 1876/4885 |
| US-20050085502-A1 | Phenyl-substituted imidazopyridines | AADAC, DPP4, DPP3 | HRH3 701/4885SMN1; SMN2 2726/4885MAPK1 4541/4885 |
| US-20100190753-A1 | Methods and Compositions for Treating Amyloid-Related Diseases | APP, PSEN1, PSEN2 | HRH3 1636/4885SMN1; SMN2 50/4885MAPK1 4043/4885 |
| US-20050143462-A1 | Pharmaceutical drug candidates and methods for preparation thereof | MPST, TTR, STS | HRH3 3688/4885SMN1; SMN2 304/4885MAPK1 1723/4885 |
| US-20080027097-A1 | PHARMACEUTICAL DRUG CANDIDATES AND METHODS FOR PREPARATION THEREOF | MPST, TTR, STS | HRH3 3688/4885SMN1; SMN2 304/4885MAPK1 1723/4885 |
| US-20050085501-A1 | Phenyl-substituted imidazopyridines | AADAC, DPP4, DPP3 | HRH3 701/4885SMN1; SMN2 2726/4885MAPK1 4541/4885 |
| US-20030175803-A1 | Electrochemiluminescence; kinases; phosphatases | PRKACA, DUSP3, PPP6C | HRH3 4597/4885SMN1; SMN2 4776/4885MAPK1 308/4885 |
| US-20200071582-A1 | Biological Buffers with Wide Buffering Ranges | PEF1, SLC7A1, PLPBP | HRH3 431/4885SMN1; SMN2 2163/4885MAPK1 1769/4885 |
| US-20050049277-A1 | Phenyl-substituted imidazopyridines | AADAC, DPP4, DPP3 | HRH3 701/4885SMN1; SMN2 2726/4885MAPK1 4541/4885 |
| US-20050090523-A1 | 2-(substituted phenyl)imidazo[1,2-a]pyridine compounds; use to treat disorders mediated by the histamine H3 receptor such as sleep disorders, attention deficit hyperactivity disorder, or Alzheimer's disease; 2-[4-[3-(Piperidino)propylamino]phenyl]-8-methylimidazo[1,2-a]pyridine for example | HRH3, HRH4, HTR2C | HRH3 1/4885SMN1; SMN2 1878/4885MAPK1 2682/4885 |
| US-20020006934-A1 | Phenyl-substituted imidazopyridines | AADAC, DPP4, DPP3 | HRH3 701/4885SMN1; SMN2 2726/4885MAPK1 4541/4885 |
| US-20050267183-A1 | Selective estrogen receptor modulators | ESR2, ESR1, GPER1 | HRH3 2450/4885SMN1; SMN2 867/4885MAPK1 2041/4885 |
| US-20080015180-A1 | Methods and compositions for treating amyloid-related diseases | APP, PSEN1, PSEN2 | HRH3 1636/4885SMN1; SMN2 50/4885MAPK1 4043/4885 |
| US-20210246344-A1 | Biological buffers with wide buffering ranges | PEF1, SLC7A1, PLPBP | HRH3 430/4885SMN1; SMN2 2174/4885MAPK1 1664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.